Atlas Trials

BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia

Clinical trial NCT05102162 · TERMINATED

Trial details

NCT number
NCT05102162
Sponsor
University of Florida
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Pneumonia
Start date
2021-12-17
Primary completion
2023-02-28
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.